Skip to main content
. Author manuscript; available in PMC: 2018 Jun 6.
Published in final edited form as: Cell Metab. 2017 Apr 13;25(6):1282–1293.e7. doi: 10.1016/j.cmet.2016.12.018

Figure 3. Impairment in ETC complex I, but not complex IV, reduce Treg suppressive function.

Figure 3

(A) NAD/NADH and (B) ATP measurements in heart tissue from age and gender matched ND6mut (ETC complex I defect), CO1mut (ETC complex IV defect) and co-housed wild type control mice (4–6/group). ND6mut mice show reduced NAD relative to NADH, with normal ATP production. CO1mut mice are capable of NADH to NAD oxidation, but show impaired ATP production. (C, D) Comparison of the ability of ND6mut versus control Tregs to suppress proliferation of CFSE-labeled T-effector (Teff) cells in vitro, stimulated with anti-CD3ε mAb and irradiated CD90.2 antigen presenting cells. (C) Representative flow cytometry and (D) cumulative analysis showing Treg from aged ND6mut mice have weaker suppressive Treg function versus results for WT Treg. Student’s t-test; data pooled from 11 observations and four independent experiments. (E) Comparison of the ability of CO1mut versus control Tregs shows no difference in suppressive function. (F) Cumulative data; Student’s t-test. Data pooled from 10 observations and three independent experiments. All wild type controls were age- and gender matched. * indicates p<0.05, and error bars indicate SEM.